276 L-sulfolactate dehydrogenase-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 10 | 2.7 | 3.67× | not tested | |
| Organoheterocyclic compounds | 1 | 1.5 | 0.66× | not tested | |
| Organic acids and derivatives | 1 | 1.5 | 0.66× | not tested | |
| Organic oxygen compounds | 1 | 2.0 | 0.51× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 24 |
| DB09459 | TLA | L-tartaric acid | 6 |
| DB02338 | NDP | NADPH | 5 |
| DB00157 | NAI | NADH | 4 |
| DB02543 | PYC | Pyrrole-2-Carboxylate | 2 |
| DB04343 | GLV | Glyoxylic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 24 |
| TLA | L(+)-TARTARIC ACID | 6 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 5 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 4 |
| PYC | PYRROLE-2-CARBOXYLATE | 2 |
| GLV | GLYOXYLIC ACID | 1 |
| NAmetal | SODIUM ION | 1 |